Can a natural supplement soothe Chemo's painful side effects?
NCT ID NCT05246670
Summary
This study is testing if a dietary supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer survivors. About 88 participants who have had these symptoms for at least 3 months will take either PEA or a placebo pill for 8 weeks. Researchers will measure changes in pain and quality of life to see if PEA is safe and helpful.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carle Cancer Center NCI Community Oncology Research Program
Urbana, Illinois, 61801, United States
-
Cone Health Cancer Center
Greensboro, North Carolina, 27403, United States
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic Health System Eau Claire Hospital-Luther Campus
Eau Claire, Wisconsin, 54703, United States
-
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, 54601, United States
-
Middlesex Hospital
Middletown, Connecticut, 06457, United States
-
Rapid City Regional Hospital
Rapid City, South Dakota, 57701, United States
-
Siouxland Regional Cancer Center
Sioux City, Iowa, 51101, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.